KENNETH BROMBERG, M.D.; JAY M. ORSON, M.D.; RUTH TRIEDMAN, M.D.; PAUL CAMPOGNONE, M.S.
This content is PDF only. Please click on the PDF icon to access.
To the editor: The Committee on Prevention of Rheumatic Fever and Bacterial Endocarditis of the American Heart Association recommends oral erythromycin with or without parenteral vancomycin as bacterial endocarditis prophylaxis for dental procedures in patients allergic to penicillin or receiving continuous oral penicillin for secondary prevention of rheumatic fever (1). To study the appropriateness of this recommendation, we compared the oral flora of 30 patients receiving at least 1 month of erythromycin therapy with that of 30 age-matched control subjects.
BROMBERG K, ORSON JM, TRIEDMAN R, et al. Erythromycin-Resistant Streptococcus viridans in Oral Flora with Prolonged Erythromycin Therapy. Ann Intern Med. 1980;93:931–932. doi: https://doi.org/10.7326/0003-4819-93-6-931_2
Download citation file:
Published: Ann Intern Med. 1980;93(6):931-932.
Copyright © 2019 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use